People who reach their 80s without cardiovascular disease are more likely to suffer from the effects of dementia than a heart attack or stroke, according to a study in the Journal of the American College of Cardiology. In a small group of participants, an association was also found between zero or low levels of artery-clogging calcium deposits and a low risk of dementia and cardiovascular events, suggesting that the cardiovascular risk factors that lead to coronary heart disease could also affect the brain.
LONDON, March 31, 2016 -- (Healthcare Sales & Marketing Network) -- Sirtex (SRX.AX) announced today that the UK National Institute for Health and Care Excellence (NICE) has issued a new Medtech Innovation Briefing (MIB)[1] stating that NHS doctors and commissioners may consider SIR-Spheres Y-90 resin microspheres as an alternative to standard therapy with trans-arterial chemoembolization (TACE) or sorafenib in the treatment of patients with inoperable primary liver cancer (hepatocellular carcinoma or HCC).
LONDON, April 1, 2016 -- (Healthcare Sales & Marketing Network) -- BTG plc (BTG.L), a global specialist healthcare company, today announced the launch of LC Bead LUMI™ in the US, the first commercially available radiopaque embolic bead for the embolization of hypervascular tumors and arteriovenous malformations (AVMs). LC Bead LUMI™ is a next generation development of LC Bead®, the market leading embolic bead.
Ethicon has announced new data from a global cardiovascular Phase III clinical trial of the Evarrest fibrin sealant patch. Seventy five per cent of patients treated during aortic reconstruction surgery with Evarrest achieved haemostasis on the first attempt within three minutes and maintained haemostasis throughout the duration of the surgery.
The Gore Excluder iliac branch endoprosthesis has become the first off-the-shelf aortic branch to be approved by the US Food and Drug Administration (FDA) according to a company release.
“Promising” results have been reported from the DANCE (Dexamethasone delivered to the adventitia to enhance clinical efficacy) trial, which is studying the Bullfrog (Mercator MedSystems) delivery of anti-inflammatory GR-agonist (dexamethasone) after atherectomy to inhibit restenosis.
Drug-eluting stents as opposed to bare metal stents should be used in below-the-knee lesions, if stenting is unavoidable, suggest one-year results of the PES-BTK-70 study, which is investigating the below-the-knee arterial use of self-expanding paclitaxel-coated stents.
The first commercial implant of the AFX2 bifurcated endograft system (Endologix) in the USA has been performed at Main Medical Center in Portland. The implantation was performed by Paul Bloch, associate professor at Tufts University School of Medicine, and vascular surgeon at Main Medical Center.
Acute mesenteric ischaemia (AMI) can be successfully treated with endovascular therapy such as balloon angioplasty, according to research from the University of Eastern Finland. The study also found that AMI is a more common cause of abdominal pain among the elderly than generally thought; however, it is difficult to diagnose before bowel damage develops.
Lombard Medical has announced that the first commercial procedure in Germany using the Altura endovascular stent graft was successfully completed at the Saarland University Medical Center-Clinic for Diagnostic and Interventional Radiology, Saarland, Germany. The procedure follows the late January Leipzig Interventional Course (LINC) in Leipzig, Germany.
The US Food and Drug Administration (FDA) has confirmed the appointment of Robert Califf as its 22nd commissioner, following a US Senate vote of 88 to 4 in his favour.
ReCor Medical has been granted US Food and Drug Administration investigational device exemption approval for the RADIANCE-HTN clinical trial. This trial will measure the effect of ReCor’s Paradise renal denervation system on blood pressure, in patients with hypertension.
Boston Scientific has received CE mark for the Eluvia drug-eluting vascular stent. It is to begin commercialisation of the product immediately in countries which recognise CE mark.
Long-term follow-up results of the CREST trial show no significant difference between patients who underwent stenting and those who underwent endarterectomy with respect to the risk of periprocedural stroke, myocardial infarction, or death and subsequent ipsilateral stroke at 10 years. The rate of postprocedural ipsilateral stroke also did not differ between groups.
Nipro North America, a division of Nipro Medical Corporation, has launched the Cronus HP high-pressure, 0.035” over-the-wire percutaneous transluminal angioplasty balloon catheter.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos